Manufacturer
GLAXO WELLCOME S.A.
Contents
Ropinirole HCl
Indication
Idiopathic Parkinson's disease & idiopathic/primary restless legs syndrome. Monotherapy or in combination w/ l-dopa to control ''on-off'' fluctuations & reduce the total daily dose of l-dopa.
Instruction
May be taken with or without food.
Drug interaction
Diminished effectiveness by sulpiride or metoclopramide. Increased Cmax & AUC by ciprofloxacin, enoxacin or fluvoxamine. Increased plasma conc w/ high-dose oestrogens. Induced CYP1A2 metabolism by smoking. Caution w/ alcohol.